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Abstract
Background. Functional neurological disorder (FND), previously known as conversion dis-
order, is common and often results in substantial distress and disability. Previous research
lacks large sample sizes and clinical surveys are most commonly derived from neurological
settings, limiting our understanding of the disorder and its associations in other contexts.
We sought to address this by analysing a large anonymised electronic psychiatric health record
dataset.
Methods. Data were obtained from 322 patients in the South London and Maudsley NHS
Foundation Trust (SLaM) who had an ICD-10 diagnosis of motor FND (mFND) (limb weak-
ness or disorders of movement or gait) between 1 January 2006 and 31 December 2016. Data
were collected on a range of socio-demographic and clinical factors and compared to 644 psy-
chiatric control patients from the same register.
Results. Weakness was the most commonly occurring functional symptom. mFND patients
were more likely to be female, British, married, employed pre-morbidly, to have a carer
and a physical health condition, but less likely to have had an inpatient psychiatric admission
or to receive benefits. No differences in self-reported sexual or physical abuse rates were
observed between groups, although mFND patients were more likely to experience life events
linked to inter-personal difficulties.
Conclusions. mFND patients have distinct demographic characteristics compared with psy-
chiatric controls. Experiences of abuse appear to be equally prevalent across psychiatric
patient groups. This study establishes the socio-demographic and life experience profile of
this understudied patient group and may be used to guide future therapeutic interventions
designed specifically for mFND.
Background
Functional neurological disorder (FND), also known as conversion disorder, refers to a spec-
trum of neurological symptoms which have no known conventional neurological cause and are
assumed psychological in origin (American Psychiatric Association, 2013). A wide range of
symptoms and signs are reported, the commonest are seizures, sensory symptoms (e.g. numb-
ness or visual impairment) or motor symptoms (e.g. limb weakness, tremor, dystonia or gait
disorders). FND may begin suddenly, progress quickly, increase with attention or excessive
fatigue and disappear with distraction (Espay et al., 2018).
Establishing a population prevalence of FND is difficult due to changes in its terminology,
diagnostic criteria and the need for neurological examination prior to diagnosis. Evidence sug-
gests its incidence is 4–5 per 100 000 of the population per year (Binzer et al., 1997; Akagi and
House, 2001). A large study of neurology outpatients in Scotland found functional symptoms
were the second most common disorder after headache, affecting 16% of patients (Stone et al.,
2010a), a finding recently replicated in an Australian neurology practice (Ahmad and Ahmad,
2016).
Previous studies have shown higher rates of females with FND, usually in the range of 60–
80% (McCormack et al., 2014; Carson and Lehn, 2016; Villain et al., 2017), lower socio-
economic status (SES) (Binzer et al., 1997), lower educational attainment (Stone et al.,
2004; Deka et al., 2007) as well as lower mood and higher anxiety (Binzer et al., 1997;
Stone et al., 2010b), although the evidence on this is mixed (van der Hoeven et al., 2015).
Views regarding the connection between ethnicity and FND have been expressed over the
years, usually along the lines that somatic manifestations of distress occur more in those
from non-Western backgrounds (Lambo, 1956; Kleinman, 1980; Kleinman, 1982), although
comparing rates is difficult due to the disparity in sampling methods and measures used as
well as the diagnostic criteria employed (Brown and Lewis-Fernández, 2011).
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Childhood sexual and physical abuse rates are higher in FND
compared with neurological disorders or healthy controls (Roelofs
et al., 2005b; Sharpe and Faye, 2006; Ludwig et al., 2018). Studies
in neurology settings report lower abuse rates compared with
studies in psychiatry settings (Ludwig et al., 2018). Estimating
the rates of abuse is challenging and depends on the type of mea-
sures used and the skill of the interviewer, amongst other factors.
Patients with functional symptoms had the same rate of paid
employment as patients with symptoms that were ‘largely’ or
‘completely’ explained by organic conditions, however amongst
unemployed patients, patients with functional symptoms were
more often unemployed due to ill health and were more likely
to receive incapacity benefit and disability living allowance
(Carson et al., 2011). The higher rate of benefits is likely explained
by the increased physical and mental ill health experienced by
functional cases in this study. Functional disorders occur in all
areas of medicine and often result in chronic and severe symp-
toms with attendant high health and social care costs.
Bermingham et al. (2010) reported that the incremental cost
incurred by somatising patients is £3 billion per year, accounting
for 10% of total NHS expenditure.
Most studies on motor FND (mFND) have originated in neur-
ology clinics, and are characterised by low sample sizes and lack
control groups (Factor et al., 1995; Binzer et al., 1997; Crimlisk
et al., 1998; Schrag et al., 2004; Ertan et al., 2009; van der
Hoeven et al., 2015; Garcin, 2018). This could lead to overesti-
mates of abuse risk and co-morbid psychiatric disorders and
underestimates of physical illness comorbidities.
This study addresses the imbalance in knowledge on mFND
patients within psychiatric settings. We aimed to establish the
socio-demographic, health and clinical characteristics, and pos-
sible symptom precipitants of mFND patients referred to a
large psychiatric NHS Trust and compare outcomes to an other-
wise random sample of psychiatric patients derived from the same
database but matched for time of presentation.
Methods
Design and source of clinical data
This was a case–control study of mFND patients in contact with
secondary mental health services in South London and Maudsley
(SLaM) Foundation Trust between 1 January 2006 and 31
December 2016. Data were obtained from the SLaM Biomedical
Research Centre’s (BRC) ‘Clinical Records Interactive Search’
(CRIS) database. The database contains anonymised electronic
health records from SLaM, the largest provider of secondary men-
tal health care in Europe. CRIS holds records on over 250 000
anonymised individuals referred to SLaM services (Perera et al.,
2016). This is a single online system where daily activities, medi-
cation, diagnoses, correspondence, health scores and all patient
information is recorded. Relevant records can be retrieved using
search terms of the database’s structured fields such as diagnoses
or from searches of free text fields (e.g. clinical notes and
correspondence).
Study setting and participants
SLaM provides inpatient and community services for a catchment
population of over 1.5 million people living in southeast London
and also receives national referrals for FND. All participants were
receiving mental healthcare in SLaM.
mFND cases included all patients aged over-18 with a primary
or secondary diagnosis of ‘Conversion disorder with motor symp-
tom or deficit’ (ICD-10 code: F44.4). Patients with any F44 diag-
nosis and evidence of functional motor symptoms in unstructured
case notes or correspondence were also included as were patients
with a confirmed mFND diagnosis in their case notes. See ‘online
Supplementary Materials’ for a comprehensive list of the search
strategies.
Our control group comprised contemporaneous SLaM
patients who received any non-functional (i.e. non-F44) psychi-
atric diagnosis on the succeeding day the mFND patient received
their diagnosis. Patients aged under-18 and those with a neurode-
generative disease of old age or an intellectual disability (F70–
F79) diagnosis were excluded. We used a random number gener-
ator from the website, random.org to select controls from the
search list and adopted a case–control ratio of 1:2.
Ethical approval
CRIS has received ethical approval from the Oxfordshire Research
Ethics Committee C (08/H0606/71+5) as an anonymised dataset
for mental health research. Ethical approval as an anonymised
database for secondary analysis was granted in 2008, and renewed
for a further 5 years in 2013. This study was approved by a
patient-led NIHR BRC CRIS oversight committee (CRIS 14-101).
Outcome measures
Data were extracted from structured fields in CRIS (e.g. dates
and diagnoses) and unstructured clinical notes and correspond-
ence. Socio-demographic characteristics included date of birth,
gender, ethnicity, marital status, receipt of welfare benefits, hous-
ing status, employment and pre-morbid employment status and
type. Clinical data included age at psychiatric symptom onset,
the nature of cases’ motor symptoms, smoking status, psychiatric
inpatient history and comorbid physical health conditions.
Information about experiences of physical or sexual childhood
or adult abuse exposure was collected from free text notes. Where
no mention of abuse was mentioned, this was coded as ‘not
known’ and removed from frequency calculations. The rate of
unknown information is reported.
Any available information on possible symptom precipitants
was collected from CRIS’s unstructured text. All references in
patients’ clinical records to possible precipitants were noted,
which comprised any noted life event, at any stage of their life.
This information was taken from referral letters, clinicians’
notes and case reviews. No exclusion criteria were applied and
categorisation of events occurred after data collection. Events
were then classified as those occurring in early life and events
occurring after the age of 18. Our method is similar to the quali-
tative classification method utilised with the same database by Bell
et al. (2018).
Statistical analysis
SPSS for Windows (SPSS v21.0, Chicago, Illinois, USA) and
Microsoft Excel (Microsoft Office Professional Plus 2010,
Version 14.0.7015.1000) were used to analyse data.
Socio-demographic and clinical characteristics were analysed
using descriptive statistics. Proportions were used to describe cat-
egorical data, and means and standard deviations for continuous
variables. Odds ratios (OR) with 95% confidence intervals (CI)
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compared unadjusted event rates. Two binary logistic regression
analyses were performed to compare socio-demographic charac-
teristics of mFND patients with control patients and precipitating
events, respectively.
Results
Socio-demographic characteristics
Our search returned 322 mFND and 644 control patients
The control group comprised patients with mood disorders
(22.7%), mental and behavioural disorders due to psychoactive
substances (17.4%), schizophrenia, schizotypal and delusional dis-
orders (14%), factors influencing health status and contact in
health services (Z00–Z99) (13.8%), unspecified mental disorders
(F99) (11.3%), neurotic, stress and somatoform disorders
(10.9%), behavioural syndromes associated with physiological dis-
turbances (2.6%), behavioural and emotional disorders with onset
in childhood and adolescence (2.2%), disorders of personality and
behaviour (1.9%) and other disorders (3.2%).
The socio-demographic and clinical characteristics of the
mFND patients are described in Table 1. There were 238 females
(73.9%) and 84 males (26%) in the mFND group, a significantly
higher proportion of females compared with control patients (OR
2.52, 95% CI 1.9–3.4, p = 0.001).
The mean age of mFND patients was 46.1 years (s.d. = 13.4) v.
47.6 years (S.D. = 16.2) for controls (not significantly different).
The mean age at which mFND patients first began experiencing
psychiatric symptoms was 33.2 years (s.d. 14.6), similar to that
of control patients (32.5 years, S.D. 17.8).
British patients constituted 60.6% of the mFND group, com-
pared with 50.9% in the control group (OR 1.5, 95% CI 1.1–1.9,
p = 0.001). mFND patients were more likely to be married, in a
civil partnership or cohabiting (43.4%) compared with 17.7% in
the control group (OR 4, 95% CI 2.9–5.4, p = 0.001).
mFND patients were more likely to be employed than control
patients (24.5% v. 17.4%, OR 1.5, 95% CI 1.1–2.2, p = 0.02).
Employment was stratified by gender, but no differences between
groups emerged. Control patients were more likely to receive wel-
fare benefits (55.7%) compared with mFND patients (47.8%) (OR
0.73, 95% CI 0.55–0.96, p = 0.03). Of patients receiving benefits,
mFND patients were more likely to receive disability living allow-
ance compared with controls (χ2 = 17.7, df = 1, p = 0.001).
In total, 19% of mFND and 8% of control patients were
employed or had been employed in care-giving roles in health,
social care, child care or mental health sectors (OR 2.63, 95%
CI 1.73–4, p = 0.001).
Patients were grouped according to whether they were carers to
a family member or friend, either formally or informally. mFND
patients were significantly more likely to act as carers (9.8%) than
control patients (2.8%) (OR 3.77, 95% CI 2–7.1, p = 0.001). The
significant difference was maintained in both males and females
after stratification by gender.
In total, 38.8% of mFND patients themselves had a carer com-
pared with 23.5% of control group participants (OR 2.06, 95% CI
1.5–2.8, p = 0.001). The significant difference was maintained
when data were stratified by gender.
Health
The type of motor and sensory symptoms affecting mFND
patients was categorised. Most participants had more than one
symptom, with the mean number of functional motor and sen-
sory symptoms equalling 2.42 (s.d. 1.1). The most commonly
reported symptom was ‘weakness’ of any type accounting for
50.3% of all reported symptoms, followed by ‘other’ motor or sen-
sory symptoms (37.9%) such as visual disturbances, facial droop,
etc., and ‘tremor’ which includes ‘tremor, spasms, jerks and tics’
(33.9%). Figure 1 outlines the rate of motor, sensory and other
co-morbid functional symptoms.
A third (33.8%) of all mFND patients had a comorbid functional
diagnosis. The most common syndromes were non-epileptic sei-
zures (16.2% of all mFND patients), irritable bowel syndrome
(7.5%) and somatoform pain disorder (4.3%). Four per cent of
patients had co-morbid functional diagnoses classified as ‘other’.
These include depersonalisation disorder, psychogenic polydipsia,
dissociative amnesia, foreign accent syndrome, somatoform dis-
order and dissociative identity disorder. Figure 1 outlines co-morbid
functional diagnoses. There were significantly more co-morbid
functional diagnoses in the mFND group (33.8%) than the 1.9%
in the control group (OR 26, 95% CI 14–48.2, p = 0.001).
In total, 38.5% of mFND patients smoked cigarettes at the time
of data collection, significantly fewer than controls at 62.6% (see
Table 1). A significantly higher proportion of mFND patients
had a co-morbid physical health condition compared with control
patients (74.5% v. 59.6%, OR 1.9, 95% CI 1.4–2.7, p = 0.001), with
‘diseases of the nervous system’ the most common illness in
mFND patients, accounting for 22.2% of all reported illness.
More control than mFND patients had at least one psychiatric
inpatient admission (43.5% v. 33.2%). Control patients spent
more days in inpatient settings with a mean of 143.3 days (s.d.
209, median 67, IQR 155) compared with mFND patients’
mean of 130.3 days (S.D. 124) (median 112 days, IQR 89, U =
11 944.5, p = 0.007). We assessed whether there were reports of
mental health problems in patients’ family members. There was
a positive history in 52.1% of mFND patients and 60% of control
patients, with no statistical difference. Amongst mFND patients,
the most common relative reported to have a mental health prob-
lem were patients’ mothers (accounting for 30.4% of all relatives),
followed by fathers (18.2%) and patients’ sons (6.1%). Similar pat-
terns were observed in the control group and there were no stat-
istical differences between groups.
Abuse
We examined clinical records for experience of childhood sexual
abuse (CSA), childhood physical abuse (CPA) and physical or sexual
abuse in adulthood. No information was available on the presence
or absence of CSA in 22.4% of mFND patients and 39.9% of control
group patients. The rate of CSA in the mFND group was 20%, simi-
lar to the 21.9% rate in the control group (OR 0.9, 95% CI 0.6–1.3, p
> 0.05). When stratified by gender, the CSA rate in female mFND
patients was 22.8% and 30.3% in female control patients. CSA
rates in male mFND patients were 11.3% and 11.2% in male control
patients. Using OR, comparing female abuse rates in both groups to
females not experiencing abuse, there was no statistical difference,
with the same finding amongst males.
Information on the presence or absence of CPA was lacking in
22% of mFND patients and 40.2% of control patients. There was
no difference in the rate of CPA in the mFND group (22.7%)
compared with the control group at 21.8%. When stratified by
gender, 24.3% of female mFND patients experienced CPA com-
pared with 27.1% of female control patients. The rate in male
mFND patients was 17.7% and 15.8% in control patients.
Psychological Medicine 3
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Table 1. Binary logistic regression analysis of socio-demographic factors associated with a motor FND (F44.4) diagnosis compared with psychiatry control group
mFND n
(%)
Control
group n (%)
Unadjusted
OR 95% CI p value
Adjusted
ORa 95% CI p value
Gender
Female 238 (73.9) 341 (53) 2.52 1.9–3.4 0.001 2.5 1.2–5.1 0.01
Male 84 (26.1) 303 (47) Reference Reference
Ethnicity
British 195 (60.6) 328 (50.9) 1.5 1.1–1.9 0.005 1.7 0.9–3.2 >0.05
Any other ethnic group 127 (39.4) 316 (49.1) Reference Reference
Marital status
Married, civil partner or cohabiting 141 (43.4) 111 (17.7) 4 2.9–5.4 0.001 7.6 3.4–17 0.001
Single, divorced, separated,
widowed
163 (53.6) 515 (82.3) Reference Reference
Not known 18 (5.6) 18 (2.8)
Work
Employed 73 (24.5) 104 (17.4) 1.5 1.1–2.2 0.01 1 0.4–2.5 >0.05
Unemployed 225 (75.5) 492 (82.6) Reference Reference
Not known 24 (7.5) 48 (7.5)
Employed pre-morbidly 246 (87.5) 385 (75) 2.34 1.6–3.5 0.001 4.9 1.7–14 0.003
Not employed pre-morbidly 35 (12.5) 128 (25) Reference Reference
Not known 41 (12.7) 131 (20.3)
Receives benefits 143 (47.8) 337 (55.7) 0.73 0.6–0.9 0.03 2.4 1.1–5.2 0.03
Does not receive benefits 156 (52.2) 268 (44.3) Reference Reference
Not known 23 (7.1) 39 (6.1)
Carers
Social or health care worker 54 (19) 46 (8.2) 2.63 1.7–4 0.001 1.6 0.6–4.0 >0.05
Non-social or health care worker 230 (81) 515 (91.8) Reference Reference
Not known 38 (11.8) 83 (12.9)
Carer to family or friends 28 (9.8) 16 (2.8) 3.77 2–7.1 0.001 1.1 0.3–5.0 >0.05
Not a care to family or friends 257 (90.2) 553 (97.2) Reference Reference
Not known 37 (11.5) 75 (11.6)
Patients has a carer 107 (38.8) 128 (23.5) 2.06 1.5–2.8 0.001 2.8 1.4–5.7 0.005
Patients without a carer 169 (61.2) 416 (76.5) Reference Reference
Not known 46 (14.3) 100 (15.5)
Health
Smoker 70 (38.5) 206 (62.2) 0.38 0.3–0.6 0.001 0.8 0.4–1.5 >0.05
Non-smoker 112 (61.5) 125 (37.8) Reference Reference
Not known 140 (43.5) 313 (48.6)
Physical health condition 219 (74.5) 326 (59.6) 1.9 1.4–2.7 0.001 3.9 1.9–8.1 0.001
No physical health condition 75 (25.5) 221 (40.4) Reference Reference
Not known 28 (8.7) 97 (15.1)
Psychiatric inpatient stay 107 (33.2) 280 (43.5) 0.65 0.5–0.9 0.002 0.40 0.2–0.7 0.03
No psychiatric inpatient stay 215 (66.8) 364 (56.5) Reference Reference
Abuse
History of child sexual abuse 50 (20) 85 (21.9) 0.89 0.6–1.3 >0.05 1.1 0.5–2.6 >0.05
(Continued )
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No information was available on adult physical or sexual abuse
in 20.2% of mFND patients and 37.9% of control group patients.
The rate of adult physical or sexual abuse in mFND patients was
27.2% which did not significantly differ from the rate in the con-
trol group of 21%. All comparisons are outlined in Table 1.
Predictors of mFND
To assess the socio-demographic variables that might predict an
mFND diagnosis, we conducted a binary logistic regression ana-
lysis performed amongst all patients with a diagnosis of mFND.
mFND was the dependent variable and our independent variables
are outlined in Table 1. The overall prediction was 57.1% in this
model. The Cox and Snell pseudo R2 was 0.45, indicating that the
fit of the model to the data was moderate.
In the adjusted model, factors that predict an mFND diagnosis
include being female (OR 2.5, 95% CI 1.2–5.1, p = 0.01), married
(OR 7.6, 95% CI 3.4−17, p = 0.001), pre-morbidly employed (OR
4.9, 95% CI 1.7–14, p = 0.003), receiving benefits (OR 2.4, 95% CI
1.1–5.2, p = 0.03), having a carer (OR 2.8, 95% CI 1.4–5.7, p =
0.005), having a physical health condition (OR 3.9, 95% CI 1.9–
8.1, p = 0.001) and being less likely to have a psychiatric admis-
sion (OR 0.4, 95% CI 0.2–0.7, p = 0.03). Britishness, being
employed, a social or health care worker, carer to family member,
smoking status and history of CSA, CPA and experience of sexual
or physical abuse in adulthood were not significant predictors of
mFND status in the adjusted model.
Life experiences
While sexual and physical abuse rates did not differ between groups,
we conducted an examination of other potential precipitants.
The classification of events in childhood and adulthood is out-
lined in Table 2. In the unadjusted analysis, a significantly lower
Table 1. (Continued.)
mFND n
(%)
Control
group n (%)
Unadjusted
OR 95% CI p value
Adjusted
ORa 95% CI p value
No history of child sexual abuse 200 (80) 302 (78.1) Reference Reference
Not known 72 (22.4) 257 (39.9)
History of child physical abuse 57 (22.7) 85 (22.1) 1.03 0.71–1.5 >0.05 0.8 0.3–2.0 >0.05
No history of child physical abuse 194 (77.3) 300 (77.9) Reference Reference
Not known 71 (22) 259 (40.2)
History of adult SA or PA 70 (27.2) 84 (21) 1.4 0.98–2 >0.05 1.9 0.8–4.6 >0.05
No history of adult SA or PA 187 (72.8) 316 (79) Reference Reference
Not known 65 (20.2) 244 (37.9)
SA, sexual abuse; PA, physical abuse. p values in bold indicate that the odds ratio (OR) is statistically significant.
aAdjusted for gender, age, ethnicity, marital status, employment status, pre-morbid employment status, benefit receipt, social or health care worker status, caring for family or friends, having
a carer, smoking status, the presence of a physical health condition, stay in a psychiatry inpatient setting, history of child sexual abuse, history of child physical abuse, history of adult sexual
or physical abuse.
Fig. 1. Proportion of functional motor and sensory symptoms and comorbid functional disorders in mFND patients.
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Table 2. Binary logistic regression of possible precipitant events occurring in childhood or adulthood associated with motor FND (F44.4) diagnosis compared with psychiatry control group
mFND n
(%)
Control group n
(%)
Un-adjusted
OR 95% CI p value
Adjusted
ORa 95% CI p value
Events in childhood
Left or abandoned by a parent as a childb 30 (10.5) 37 (7.1) 1.5 0.9–2.5 >0.05 1.1 0.5–2.4 >0.05
Violence between parentsb 15 (5.3) 31 (6) 0.87 0.46–1.6 >0.05 0.5 0.2–1.2 >0.05
Parents divorced or separatedb 38 (13.2) 63 (12.2) 1.1 0.7–1.7 >0.05 1.2 0.6–2.2 >0.05
In care, fostered or adopted as a childb 14 (4.9) 35 (6.8) 0.7 0.4–1.3 >0.05 0.9 0.4–2.5 >0.05
Bullied in primary or secondary schoolb 51 (17.8) 47 (9.1) 2.16 1.4–3.3 0.001 2.0 1.1–3.7 0.03
Took drugs under-18b 3 (1) 34 (6.6) 0.15 0.05–0.5 0.002 0.3 0.6–1.5 >0.05
Events in adulthood
Financial difficulties (e.g. debt, homelessness)b 35 (12.2) 59 (11.4) 1.08 0.7–1.7 >0.05 1.5 0.7–3.1 >0.05
Bereavement but unlikely a precipitantb 49 (17.1) 64 (12.4) 1.5 0.97−2.2 >0.05 1.5 0.9–2.7 >0.05
Bereavement as likely precipitantb 54 (18.8) 75 (14.5) 1.4 0.9–2 >0.05 1.6 0.9–2.9 >0.05
Interpersonal problems in the workplace, school or universityb 65 (22.6) 36 (6.9) 3.9 2.5–6.1 0.001 4.6 2.4–8.9 0.001
Involved in a legal disputeb 20 (7) 4 (0.8) 9.6 3.3–28 0.001 7.0 0.7–70 >0.05
Problems within a sexual relationship (e.g. divorce)b 92 (32.1) 120 (23.2) 1.6 1.1–2.2 0.006 1.7 1–2.9 0.04
Accident or assault but unlikely a precipitantb 19 (6.6) 9 (1.7) 4 1.8–8.9 0.001 10.3 2.6–40.6 0.001
Accident or assault a likely precipitantb 44 (15.3) 12 (2.3) 7.6 3.9–14.7 0.001 5.8 2.2–15.3 0.001
Affected by war or political turmoilb 20 (6.9) 17 (3.3) 2.2 1.13–4.3 0.02 5.5 1.9–15.9 0.002
Socially isolatedb 5 (1.7) 9 (1.7) 1 0.3–3 >0.05 1.1 0.1–8.0 >0.05
Abusing drugs or alcoholb 23 (8) 150 (29) 0.2 0.13–0.3 0.001 0.3 0.6–1.4 0.001
Family member unwellb 63 (22) 33 (6.4) 4.1 2.6–6.5 0.001 5.2 2.7–9.9 0.001
Organic disease or injuryb 67 (23.3) 38 (7.3) 3.8 2.5–5.9 0.001 5.7 3–10.9 0.001
Complication in pregnancy (e.g. postnatal depression, miscarriage or
still birth)b
22 (10.4) 33 (11.7) 0.88 0.5–1.6 >0.05 0.5 0.2–1.1 >0.05
p values in bold indicate that the odds ratio (OR) is statistically significant.
aAdjusted for gender, age and life events.
bReference: patients not experiencing the event.
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proportion of mFND patients reported taking drugs under the age
of 18 (1% v. 6.6%, p = 0.002), and a higher proportion of mFND
patients experienced bullying before the age of 18 compared with
the control group (17.8% v. 9.1%, p = 0.001). Following stratifica-
tion by gender, this significant difference remained for both men
and women.
For events in adulthood, the unadjusted analysis found mFND
patients experienced significantly higher rates of workplace,
school or university problems compared with the control group
(22.6% v. 6.9%, p = 0.001), were more likely to be involved in a
legal dispute (7% v. 0.8%, p = 0.001), to report problems within
a sexual relationship (32.1% v. 23.2%, p = 0.006), to have experi-
enced an accident or assault (15.3% v. 2.3%, p = 0.001), to be
affected by war or political upheaval (6.9% v. 3.3%, p = 0.02), to
have an unwell family member (22% v. 6.4%, p = 0.001) and to
have had an organic illness or injury precipitating their symptom
onset (23.3% v. 7.3%, p = 0.001). mFND patients were signifi-
cantly less likely to report abusing drugs or alcohol compared
with the control group (8% v. 29%, p = 0.001).
A binary logistic regression analysis accounting for gender, age
and all other life events produced similar OR; however, the
adjusted model found no difference in proportions of those taking
drugs aged under-18, or those involved in legal disputes.
Discussion
Main findings
Research on mFND patients is limited. To our knowledge, the
current study is the largest of its kind in this patient group. We
identified 322 mFND patients from a mental health service case
register of 250 000 patient records. The associations between
mFND and life events, demographic, social, occupational and
health characteristics were investigated and compared with a
large unselected contemporaneous sample of patients with other
mental health disorders.
It is well-established that mFND has a female preponderance
(Binzer et al., 1997; Stone et al., 2009; Stone et al., 2010a;
McCormack et al., 2014), again confirmed in our study.
Women may be more likely to perceive and label noxious bodily
sensations as a result of heightened body vigilance (Warner,
1995), societal gender differences may persuade more women to
communicate bodily distress (Mechanic, 1972) or seek help for
somatic symptoms from medical experts (Nathanson, 1977).
There may be underlying genetic vulnerabilities, personality pre-
dispositions (McCrae et al., 2000) and hormonal differences could
mediate responses to stressful life events leaving women more vul-
nerable to symptom development (Li and Graham, 2017).
Alternatively, clinicians may be more likely to diagnose FND in
women or specifically ask about experiences of trauma or abuse
due to cultural and historical stereotypes of ‘hysteria’ as a specif-
ically female malady.
Evidence on level of education and SES in mFND is mixed.
Some studies report no difference in SES or education between
cases and neurological or healthy controls (Roelofs et al., 2005a;
Stone et al., 2010b; van der Hoeven et al., 2015), with others
reporting lower education in mFND patients (Stefansson et al.,
1976; Binzer et al., 1997). We do not have a measure of SES
but proxy measures show increased SES in mFND patients com-
pared with controls. Contrary to some stereotypes, mFND
patients were less likely to receive benefits, were more likely to
be employed pre-morbidly and were more likely to be married,
even when gender was controlled. The argument that less edu-
cated patients might use functional symptoms as a coping mech-
anism is not borne out in this study. These findings (and others)
emerged because of what we contend to be a fair comparison with
other psychiatric service users where employment is expected to
be lower, and receipt of benefits, higher than the national average.
Employment in care-giving positions within health and social
care industries amongst mFND patients is worth noting. Studies
in movement disorders clinics have found no difference between
mFND patients and controls (Kenney et al., 2007; Perry et al.,
2017), although McCormack et al. (2014) report high rates of
this employment. One theory is that working in healthcare roles
or observing unwell family members allows the modelling of
neurological symptoms (Shill and Gerber, 2006; Hotopf et al.,
2018).
Our adjusted regression analysis did not find any difference in
paid care work between mFND and control patients. Gender is
likely to partly account for the relationship between employment
in the health and social care industry and mFND status.
Employment data support this as healthcare workers account
for 6% of the UK’s economy; and four-fifths are women (Yar
et al., 2006). Similar trends in gender are seen in the status of non-
paid carers. Census data from the Office for National Statistics
(2011) found 58% of all carers are female. A combination of
age and gender likely predicts carer status as in the general popu-
lation, the peak age of caring is between 50 and 64 years of age,
but one in four women aged 50–64 have caring responsibilities
compared with one in six men of the same age.
In our study, weakness, or the loss of motor function, was the
most common functional motor symptom. Studies from move-
ment clinics report tremor as the most prevalent functional symp-
tom (Hinson and Haren, 2006; Kranick et al., 2011; van der
Hoeven et al., 2015; Park, 2018), reflecting a possible referral
bias to those clinics. Weakness has been described as the most
common functional symptom in an acute stroke centre
(Gargalas et al., 2015), a tertiary psychiatric inpatient setting
(McCormack et al., 2014) and a neurological clinic (Crimlisk
et al., 1998). While weakness was common, in our study most
patients had more than one functional symptom, a finding
reported elsewhere (Stone et al., 2010b). Our cross-sectional
design restricted us from establishing the evolution or prognosis
of symptoms but it is likely symptoms do not remain static and
can worsen or improve with time.
We found mFND patients were less likely to have a hospital
admission compared with controls. While we do not know why
patients were admitted or if admissions were voluntary or involun-
tary, it is likely that the majority of mFND admissions were to the
Lishman Unit, a specialist rehabilitation centre. Amongst control
patients, those with an admission history were most commonly
schizophrenia, schizotypal and delusion disorder and affective dis-
order patients, meaning they likely had qualitatively different kinds
of admissions. In our unadjusted analysis, mFND patients were
less likely to smoke than controls. We hypothesised that this
might be due to the high proportion of schizophrenia patients
in our control group. In a sensitivity analysis, we removed patients
with a schizophrenia diagnosis from the control group but the sig-
nificant difference in smoking remained. In our adjusted model
however, the difference disappeared, a finding similar to a general
practice survey comparing patients with persistent medically
unexplained symptoms to those with medical diagnoses
(Dirkzwager and Verhaak, 2007). Nonetheless, while smoking
rates are certainly no higher than other psychiatric groups, the
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rate of smoking of 38.5% in mFND patients is substantially higher
than the population prevalence in English adults of 19% (Health
and Social Care Information Centre, 2015). This may be surpris-
ing in a group which one could argue may be more
health-anxious or body-focused. Smoking might help reduce
patients’ anxiety or emerge due to distorted health behaviour
beliefs. Future studies examining patients’ knowledge of general
health advice might help explain this and other health behaviours.
Life events
We found no significant differences in rates of childhood sexual
or physical abuse or adulthood sexual or physical abuse between
groups.
The 20% rate of CSA is slightly lower than previously reported
in functional disorders in psychiatric settings, which range from
24% to 26.3% (Roelofs et al., 2002; Sar et al., 2004; Akyuz et al.,
2017) (this excludes studies which select only non-epileptic seiz-
ure patients). Similarly, our CPA rate of 22.7% is moderately
lower than previously reported rates in psychiatric settings,
which varies between 23% and 28% (Roelofs et al., 2002;
McCormack et al., 2014; Farooq and Yousaf, 2016; Nicholson
et al., 2016). Our rates are also lower than those reported in a
recent meta-analysis which reported CSA and CPA rates of 24%
and 30%, respectively, although this includes heterogeneous func-
tional symptoms and service settings (Ludwig et al., 2018).
The somewhat lower childhood abuse rates reported in our
study may be an underestimation due to the observational, retro-
spective method and lack of structured interviewing, as studies
utilising interview techniques report higher CSA rates in FND
(Ludwig et al., 2018). In our study, no mention of abuse in clinical
records was classified as missing data but this may mask 5–10% of
the true event rate. There were higher levels of missing data on
abuse in control group patients compared with mFND patients,
suggesting clinicians may be more likely to ask about trauma
and childhood history in mFND patients.
This potential lack of methodological sensitivity would be
expected to affect both groups equally. When stratified by gender,
rates of childhood sexual and physical abuse are higher amongst
females in both groups compared with their male counterparts,
suggesting risk of childhood abuse is higher amongst females,
but not a specific risk amongst female mFND patients. That
abuse rates did not differ between mFND and control patients
is an important finding which contradicts some theories of
FND aetiology. There is evidence that in case–control studies,
rate differences are attenuated when psychiatric controls rather
than neurological or healthy controls are used (Ludwig et al.,
2018). Perhaps more pertinent is that abuse is prevalent in the
general public with retrospective surveys estimating CSA rates
in English women of 11–17% (Gorey and Leslie, 1997; Molnar
et al., 2001; Bebbington et al., 2011; Office for National
Statistics, 2016). Abuse experiences are likely to increase risk for
psychiatric morbidity generally and form a component of some
patients’ mFND development, but our findings suggest they
should not be regarded as specific to the disorder or be used as
a diagnostic indicator.
Perhaps more promising in the identification of specific risks
in mFND aetiology are the findings on life events prior to symp-
tom onset. Premorbid life experiences appear to be linked to dis-
rupted or problematic inter-personal relationships; a finding
echoed elsewhere where mFND patients had higher rates of family
conflict (Stone et al., 2004; Akyuz et al., 2017). In some cases,
functional symptoms may be a means, to help shape, negotiate
or re-define problematic social interactions (see Nicholson
et al., 2016). Evidence exists for reduced or impaired emotional
processing in FND (Waller and Scheidt, 2006; Demartini et al.,
2014) and this might disrupt the development of early inter-
personal skills. The causal pathway is unlikely to be linear as
the existence of functional symptoms may themselves exacerbate
or undermine personal interactions and relationships. Where
such a process plays a role in symptom development, patients
might benefit if the management of inter-personal conflicts and
the bolstering of inter-personal skills were incorporated into psy-
chotherapeutic approaches for the condition.
Strengths and limitations
The strength of this study is its large sample size. The study uses
an innovative source to access a larger sample of patients than
would be possible to recruit in clinical research. Full electronic
health records retrieved through the CRIS database enabled access
to detailed information about mFND patients and their contact
with psychiatric services. The use of a psychiatric control group
allowed for the empirical test of differences in patient profiles
and characteristics. Our sample is more representative of the
population of patients seen in routine clinical care than would
be the case in a typical clinical trial.
Part of our search strategy involved a search of free-text clinical
notes. Given the ubiquity of synonyms associated with a func-
tional diagnosis, it is possible our search terms were not exhaust-
ive and more mFND patients were present in the database than
were detected in our study. Secondly, while our sample can be
taken as encompassing a representative greater London NHS psy-
chiatric catchment-area population, it also included referrals to a
tertiary neuropsychiatry service placing limitations on our ability
to generalise findings to services without specialist neuropsych-
iatry input and to other NHS Trusts outside London. It is likely
our mFND patients include more severely affected patients and
of course our study only represents mFND patients who have
had at least some contact with psychiatric clinical services.
Thirdly, clinicians’ own biases or preferences in clinical formula-
tions and note writing will have shaped the free-text clinical
records, although this bias is unlikely to be systematic or to affect
our between-group comparisons. Furthermore, we have empha-
sised factual information, albeit uncorroborated over clinical
interpretation. Finally, it was not possible to blind the researcher
to case–control status, so we cannot discount the possibility of
observer bias in data extraction.
In conclusion, mFND patients have distinct demographic
characteristics when compared with psychiatry controls attending
the same NHS Trust. While some of our findings are unsurpris-
ing, such as the female preponderance and chronicity, reliance on
carers and associations with life stress, others are not necessarily
in line with the clinical stereotypes of the mFND patient. For
example, there was no increase of CSA; ethnic background and
nationality were less diverse, there were fewer hospital admissions
and there were higher levels of employment. By establishing the
socio-demographic and life experience profile of this understud-
ied patient group, we hope to stimulate novel psychosocial
interventions.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291719000266.
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